A Washington, D.C. federal appeals court has extended drugmaker filing deadlines and has pushed back oral arguments in litigation surrounding HRSA's authority to approve 340B rebates.
Federal Court Extends Deadlines in Drugmakers’ 340B Rebate Appeals